Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
is a pharmaceutical company that develops therapies for the treatment of ultra-rare diseases with critical unmet medical needs. The Zacks Consensus Estimate for its current year earnings has been revised 15.6% downward over the last 60 days.
is a provider of lease-purchase solutions through e-commerce merchants. The Zacks Consensus Estimate for its current year earnings has been revised 17.9% downward over the last 60 days.
is a real estate investment trust engaged in leasing, managing, developing, and redeveloping properties. The Zacks Consensus Estimate for its current year earnings has been revised almost 7.3% downward over the last 60 days.
View the entire
Zacks Rank #5 List.
Zacks’ Top Picks to Cash in on Electric Vehicles
Big money has already been made in the Electric Vehicle (EV) industry. But, the EV revolution has not hit full throttle yet. There is a lot of money to be made as the next push for future technologies ramps up. Zacks’ Special Report reveals 5 picks investors
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report